PreciseDx Company

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Invests into

Industry: Data processing
Headquarters: New York, New York, United States
Founded Date: 2019-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 10750000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-01-11
Last Funding Type: Series A

Visit Website
Register and Claim Ownership